Literature DB >> 8613217

Renal response to L-arginine in salt-sensitive patients with essential hypertension.

Y Higashi1, T Oshima, M Watanabe, H Matsuura, G Kajiyama.   

Abstract

This study examined whether disturbances in nitric oxide formation contribute to renal dysfunction in salt-sensitive essential hypertensive patients. We evaluated the effects of intravenous administration of L-arginine (500 mg/kg given over 30 minutes) on systemic and renal hemodynamics in 23 patients with mild essential hypertension during 1 week of a low NaCl diet (50 mmol/d) followed by 1 week of a high NaCl diet (340 mmol/d). Patients were classified as salt sensitive (n=10) or salt resistant (n=13) based on salt-induced changes in their blood pressures. Salt loading increased renal vascular resistance but not renal plasma flow in salt-sensitive patients. The L-arginine-induced renovascular relaxation was significantly reduced by a high NaCl diet (renal vascular resistance: low NaCl -12.4 +/- 2.3% versus high NaCl -7.1 +/- 1.8%, P < .001) in salt-sensitive patients, whereas it was unchanged in salt-resistant patients. The increase in plasma cGMP in response to L-arginine was also reduced by a high NaCl diet in the salt-sensitive patients (low NaCl 49 +/- 7% versus high NaCl 36 +/- 8%, P < .05) but not in the salt-resistant patients (low NaCl 51 +/- 6% versus high NaCl 58 +/- 6%). These findings suggest that NaCl loading in salt-sensitive patients with mild essential hypertension reduces the ability of L-arginine to produce nitric oxide in the endothelium of the renal vasculature.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613217     DOI: 10.1161/01.hyp.27.3.643

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

1.  The antihypertensive effect of arginine.

Authors:  Sudesh Vasdev; Vicki Gill
Journal:  Int J Angiol       Date:  2008

Review 2.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

3.  Small Amounts of Inorganic Nitrate or Beetroot Provide Substantial Protection From Salt-Induced Increases in Blood Pressure.

Authors:  R Curtis Morris; Michal Pravenec; Jan Šilhavý; Stephen E DiCarlo; Theodore W Kurtz
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

4.  Salt inactivates endothelial nitric oxide synthase in endothelial cells.

Authors:  Juan Li; James White; Ling Guo; Xiaomin Zhao; Jiafu Wang; Eric J Smart; Xiang-An Li
Journal:  J Nutr       Date:  2009-01-28       Impact factor: 4.798

Review 5.  Functional foods for augmenting nitric oxide activity and reducing the risk for salt-induced hypertension and cardiovascular disease in Japan.

Authors:  Theodore W Kurtz; Stephen E DiCarlo; Michal Pravenec; R Curtis Morris
Journal:  J Cardiol       Date:  2018-03-12       Impact factor: 3.159

6.  Plasma sodium stiffens vascular endothelium and reduces nitric oxide release.

Authors:  Hans Oberleithner; Christoph Riethmüller; Hermann Schillers; Graham A MacGregor; Hugh E de Wardener; Martin Hausberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

Review 7.  No evidence of racial disparities in blood pressure salt sensitivity when potassium intake exceeds levels recommended in the US dietary guidelines.

Authors:  Theodore W Kurtz; Stephen E DiCarlo; Michal Pravenec; R Curtis Morris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-02       Impact factor: 4.733

8.  EP3 (E-Prostanoid 3) Receptor Mediates Impaired Vasodilation in a Mouse Model of Salt-Sensitive Hypertension.

Authors:  Jing Wu; Shi Fang; Ko-Ting Lu; Kelsey Wackman; Michal L Schwartzman; Sergey I Dikalov; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2021-03-01       Impact factor: 9.897

9.  Failure to vasodilate in response to salt loading blunts renal blood flow and causes salt-sensitive hypertension.

Authors:  Jing Wu; Larry N Agbor; Shi Fang; Masashi Mukohda; Anand R Nair; Pablo Nakagawa; Avika Sharma; Donald A Morgan; Justin L Grobe; Kamal Rahmouni; Robert M Weiss; James A McCormick; Curt D Sigmund
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 13.081

10.  Long-term high-dose L-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial.

Authors:  D Menafra; C de Angelis; F Garifalos; M Mazzella; G Galdiero; M Piscopo; M Castoro; N Verde; C Pivonello; C Simeoli; R S Auriemma; A Colao; R Pivonello
Journal:  J Endocrinol Invest       Date:  2022-01-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.